SEC Form 4/A · accession 0001104659-15-005906
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Sanofi
10% Owner
Period of report
Jan 22, 2015
Accepted (ET)
Feb 2, 2015 · 11:53 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 22, 2015 | P | 196,251 | $93.17 | A | 9,307,037 | I | Via wholly-owned subsidiary, Genzyme Corp. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Genzyme Corporation entered into a 60-day lock-up agreement (which may be extended under certain circumstances) which covers the 843,699 shares acquired on January 22 and January 26, 2015.
- F2Amends the price indicated in the Form 4 submitted on January 28, 2015.